Epithelial ovarian cancer: Evolution of management in the era of precision medicine-Reference-Cited by-同舟云学术

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Published:2019-05-17 Issue: Volume: Page:
ISSN:0007-9235
Container-title:CA: A Cancer Journal for Clinicians
language:en
Short-container-title:CA A Cancer J Clin

Author:

Lheureux Stephanie¹²,Braunstein Marsela³^ORCID,Oza Amit M.⁴⁵

Affiliation:

1. Clinician Investigator, Bras Drug Development Program; and Staff Medical Oncologist and Gynecology Site Leader, Princess Margaret Cancer CentreUniversity Health Network Toronto ON Canada

2. Assistant ProfessorUniversity of Toronto Toronto ON Canada

3. Scientific Associate, Division of Medical Oncology and Hematology, Princess Margaret Cancer CentreUniversity Health Network Toronto ON Canada

4. Chief, Division of Medical Oncology and Hematology; Director, Cancer Clinical Research Unit; and Director, Bras Drug Development Program, Princess Margaret Cancer CentreUniversity Health Network and Mt. Sinai Health System Toronto ON Canada

5. Professor of MedicineUniversity of Toronto Toronto ON Canada

Publisher

Wiley

Subject

Oncology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21559

Reference171 articles.

1. Cancer statistics, 2018;Siegel RL;CA Cancer J Clin.,2018

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin.,2018

3. The World Ovarian Cancer Coalition.The Every Woman Study Summary Report.2018.worldovariancancercoalition.org/wp-content/uploads/2018/11/WOCC-Every-Woman-Study-Summary-Report-Nov-08.pdf. Accessed February 18 2019.

Cited by 967 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetically actuated cisplatin-loaded nanoparticle collectives enhance drug penetration for potentiated ovarian cancer chemotherapy;Journal of Colloid and Interface Science;2025-01

2. Patient-reported symptom burden and circulating cytokines undergoing chemotherapy: a pilot study in patients with ovarian cancer;Journal of Gynecologic Oncology;2025

3. ETS1 drives EGF-induced glycolytic shift and metastasis of epithelial ovarian cancer cells;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-12

4. The Indispensable Roles of GMDS and GMDS-AS1 in the Advancement of Cancer: Fucosylation, Signal Pathway and Molecular Pathogenesis;Mini-Reviews in Medicinal Chemistry;2024-10

5. The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells;Journal of Ovarian Research;2024-09-14